Katie Jennings is a senior writer at Forbes covering healthcare, technology and AI and a co-author of the InnovationRX newsletter. She joined Forbes in 2020 and is based in Jersey City.
Plus: Kamala Harris will likely focus on abortion rights in her presidential campaign; and, here’s why we don’t have an HIV vaccine yet.doesn’t have any policy positions. However, one major healthcare-related issue that’s likely to be a centerpiece of the campaign isabout this issue than the outgoing President, and with abortion rights on the ballot in states like Arizona and Florida, it’s likely to be an issue where she believes she can swing votes.
Other healthcare issues that Harris’ campaign has highlighted in the past couple of days on various social media platforms include a Biden-Harris Administration proposal to keepfrom being reported on people’s credit reports. She’s criticizedGOP nominee Donald Trump for wanting to repeal the Biden Administration’s $35 cap on out-of-pocketplan that included private insurers and also pushed more more aggressive intervention by the government on the price of drugs.
Editor’s note: Quick note that InnovationRx will be on vacation next week. See you back here on August 7!Scientists have proven how cows have spread H5N1 bird flu across the country and infected other cows, wild birds and even mammals like cats and raccoons, according to research published in. These findings suggest it may be capable of spreading effectively between people in the future as outbreaks on poultry and dairy farms spark concerns the virus could trigger a pandemic in humans.
This marks one of the first direct observations “of efficient and sustained mammalian-to-mammalian transmission” of H5N1, Diego Diel, an associate professor of virology at Cornell and one of the study’s authors said in a press release. On the bright side, While the data clearly showed evidence of mammal-to-mammal transmission, genetic analysis has not yet revealed any signs that would lead to enhanced transmissibility in humans.
There are several big challenges with HIV that boil down to the same principle: it’s a very sneaky escape artist that is constantly changing and using decoys to evade capture by the immune system. “There's this sort of sad aphorism that we're always 10 years away from an effective HIV vaccine,” Katharine Bar, an associate professor at the University of Pennsylvania told. “But I think science doesn't necessarily move at a linear pace.
Ozempic Cancer Kamala Harris Abortion Bird Flu H5N1 HIV AIDS Gilead
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
California Goes Off The Rails—AgainSteve Forbes is Chairman and Editor-in-Chief of Forbes Media.
Read more »
InnovationRx: Oracle Debuts AI Tool To Cut Doctor’s Screen Time By 50%Katie Jennings is a senior writer at Forbes covering healthcare, technology and AI and a co-author of the InnovationRX newsletter. She joined Forbes in 2020 and is based in Jersey City.
Read more »
InnovationRx: Healthcare Venture Capital Funding Rebound?Katie Jennings is a senior writer at Forbes covering healthcare, technology and AI and a co-author of the InnovationRX newsletter. She joined Forbes in 2020 and is based in Jersey City.
Read more »
InnovationRx: The FTC Is Going After Pharmacy MiddlemenAlex Knapp is a senior editor covering healthcare, science, and cutting edge technology who joined Forbes in 2011. He's written dozens of profiles of entrepreneurs across a variety of fields and done deep dives into technological trends from superconductors to space travel to pharmaceuticals.
Read more »
InnovationRx: The FTC Is Going After Pharmacy MiddlemenAlex Knapp is a senior editor covering healthcare, science, and cutting edge technology who joined Forbes in 2011. He's written dozens of profiles of entrepreneurs across a variety of fields and done deep dives into technological trends from superconductors to space travel to pharmaceuticals.
Read more »
InnovationRx: The FTC Is Going After Pharmacy MiddlemenAlex Knapp is a senior editor covering healthcare, science, and cutting edge technology who joined Forbes in 2011. He's written dozens of profiles of entrepreneurs across a variety of fields and done deep dives into technological trends from superconductors to space travel to pharmaceuticals.
Read more »